Reviva Pharmaceuticals
RVPH
RVPH
24 hedge funds and large institutions have $13M invested in Reviva Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
1.06% less ownership
Funds ownership: 12.82% → 11.76% (-1.1%)
16% less capital invested
Capital invested by funds: $15.4M → $13M (-$2.44M)
Holders
24
Holding in Top 10
–
Calls
$9.37M
Puts
$10.1M
Top Buyers
| 1 | +$631K | |
| 2 | +$569K | |
| 3 | +$250K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$218K |
| 5 |
Belvedere Trading
Chicago,
Illinois
|
+$182K |
Top Sellers
| 1 | -$1.09M | |
| 2 | -$359K | |
| 3 | -$207K | |
| 4 |
Millennium Management
New York
|
-$178K |
| 5 |
VF
Virtu Financial
New York
|
-$108K |